Royal Bank Of Canada Acrivon Therapeutics, Inc. Transaction History

Royal Bank Of Canada

  • $425 Billion
  • Q2 2024

A detailed history of Royal Bank Of Canada transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 1,116 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,116
Previous 278 301.44%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
N/A
838 Added 301.44%
1,116 $0
Q1 2024

May 15, 2024
SELL
N/A
-2,210 Reduced 88.83%
278 $0
Q4 2023

Feb 14, 2024
BUY
N/A
927 Added 59.39%
2,488 $0
Q3 2023

Nov 14, 2023
BUY
N/A
654 Added 72.11%
1,561 $0
Q2 2023

Aug 14, 2023
BUY
N/A
242 Added 36.39%
907 $0
Q1 2023

May 15, 2023
BUY
N/A
665 New
665 $0

Others Institutions Holding ACRV

# of Institutions
53
Shares Held
23.7M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email